Cardiorenal syndrome type 2: from diagnosis to optimal management.
about
Differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction-results of a meta-analysis of randomized controlled trialsChronic Heart Failure and Comorbid Renal Dysfunction - A Focus on Type 2 Cardiorenal Syndrome.The Impact Exerted on Clinical Outcomes of Patients With Chronic Heart Failure by Aldosterone Receptor Antagonists: A Meta-Analysis of Randomized Controlled Trials.
P2860
Cardiorenal syndrome type 2: from diagnosis to optimal management.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@ast
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@en
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@nl
type
label
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@ast
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@en
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@nl
prefLabel
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@ast
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@en
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@nl
P2860
P356
P1476
Cardiorenal syndrome type 2: from diagnosis to optimal management.
@en
P2093
Cesare Baldi
Renato De Vecchis
P2860
P304
P356
10.2147/TCRM.S63255
P577
2014-11-12T00:00:00Z